All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
Tecentriq 840mg Injection
Prescription Required
Salt Composition : Atezolizumab
Manufacturer : ROCHE PRODUCTS INDIA PVT LTD
Origin of Medicine : Switzerland
1 Vial(s) Of 14ml
PAP Information : Contact us for latest updates.
Program Overview: ROCHE PRODUCTS INDIA PVT LTD, Patient Assistance Program (PAP), is dedicated to helping patients in need of Tecentriq 840mg injection . The program aims to provide eligible patients with access to the medication at a more affordable cost.
Program Benefits: Patient assistance programs (PAPs) are sponsored by pharmaceutical companies and are an important step toward lowering overall therapy costs for patients. The purpose of these initiatives is to provide financial assistance to patients so they can obtain drugs at low or no cost. MrMed will guide you through the procedure and ensure you receive your PAP medication correctly.
Contact us for the latest updates on this exclusive offer.
Eligibility Criteria: To qualify for the Tecentriq Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for Atezolizumab 840mg from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.
Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].
Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by ROCHE can avail of it without having to purchase the medication from MrMed.
Patient Assistance Programs
Program Overview: ROCHE PRODUCTS INDIA PVT LTD, Patient Assistance Program (PAP), is dedicated to helping patients in need of Tecentriq 840mg injection . The program aims to provide eligible patients with access to the medication at a more affordable cost.
Program Benefits: Patient assistance programs (PAPs) are sponsored by pharmaceutical companies and are an important step toward lowering overall therapy costs for patients. The purpose of these initiatives is to provide financial assistance to patients so they can obtain drugs at low or no cost. MrMed will guide you through the procedure and ensure you receive your PAP medication correctly.
Contact us for the latest updates on this exclusive offer.
Eligibility Criteria: To qualify for the Tecentriq Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for Atezolizumab 840mg from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.
Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].
Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by ROCHE can avail of it without having to purchase the medication from MrMed.
Introduction to Tecentriq 840mg Injection
Tecentriq 840mg injection is an anticancer medication containing the active ingredient Atezolizumab which belongs to the class of medicine called monoclonal antibody (Mab). It is indicated to treat cancer in the bladder, lungs, liver, and breast. Mab is a type of protein, to get attached to a specific target in the body. This antibody helps the immune system to fight against cancer. This medicine is used as adjuvant therapy (treatment after surgery) for lung cancer conditions where the cancer is not spread to other body parts. It is either used alone or with a combination of other anticancer medicine.
Do not take a Tecentriq 840mg injection if you are allergic to Atezolizumab or other medicine ingredients. This medicine is not recommended for children and adolescents. Notify your healthcare professional if you experience any symptoms like inflammation of the lung, liver, intestine, thyroid, adrenal glands, and pituitary gland; your doctor might prescribe other medications to prevent complications and reduce the symptoms.
Before takingTecentriq 840mg, inform your doctor if you have or ever had an autoimmune disease (the body attacks its cells), HIV infection or AIDS, past with pneumonitis (inflammation of the lung), infections like HIV/AIDS, a chronic viral infection of the liver (hepatitis B / hepatitis C). Also, notify if you have been given any live, attenuated vaccine, antibiotic within the two weeks, or any medicine to improve or suppress your immune system. Report your doctor if you are pregnant or planning to get pregnant. Use effective birth control during and even after the treatment for five months.
Uses of Tecentriq 840mg Injection
- Urothelial carcinoma
- Non-small cell lung cancer
- small cell lung cancer
- Triple-negative breast cancer
- Hepatocellular carcinoma
Therapeutic Effects of Tecentriq 840mg Injection
Tecentriq 840mg is a monoclonal antibody that blocks the interaction between PD-L1 and PD-1, which can help the T-cells recognize and attack cancer cells more effectively. By doing so, Tecentriq 840mg can stimulate the immune system to attack cancer cells and potentially slow down or stop cancer growth.
Interaction of Tecentriq 840mg Injection with other drugs
Inform your healthcare provider about all the medicines you take, including prescription, over-the-counter, nutritional, supplements, and herbal products. In particular, tell your doctor if you are taking medicines for blood pressure or other heart conditions. Certain medications may interact with Tecentriq 840mg and reduce its effectiveness by causing undesirable side effects.
More Information about Tecentriq 840mg Injection
- Store Tecentriq 840mg in the refrigerator (2°C to 8°C)
- Do not freeze
- keep the injection away from the reach of children and pets.
- If you have missed any dosing appointments, inform your doctor and schedule immediately.
How to consume Tecentriq 840mg Injection
A trained doctor or nurse should only administer it. Do not self-administer the injection. Your doctor will decide the dose and duration of your treatment based on the disease severity and other factors. It will be given as an intravenous infusion, and you will be monitored carefully for unwanted side effects. The first infusion will take around 60 minutes and must be monitored carefully. If there is no infusion reaction for the first dose, the next infusion will last 30 minutes.
Safety Advices for Tecentriq 840mg Injection
Pregnancy
Your doctor will prescribe Tecentriq 840mg only if needed, as this medicine might cause harm to the unborn baby. So notify your doctor if you are pregnant or planning to get pregnant before starting the treatment. Use effective contraception during and after the treatment for five months.
Breast Feeding
It is unknown whether Tecentriq 840mg is safe to administer in breastfeeding patients. Before starting the treatment, notify your doctor if you are breastfeeding.
Lungs
Inform your physician about any underlying lung disorders before taking Tecentriq 840mg, as this medication should be used with caution in such conditions. Consult your physician before taking this medicine. Notify your doctor if you experience any lung-related symptoms, such as difficulty breathing.
Liver
Inform your physician about any underlying liver disorders before taking Tecentriq 840mg, as this medication should be used with caution in liver disease patients. Consult your physician before taking this medicine.
Alcohol
It is unknown whether it is safe to consume alcohol with Tecentriq 840mg as this medicine makes you feel drowsy. Please consult your doctor for more information.
Driving
It is unsafe to drive while taking Tecentriq 840mg because this medicine might cause minor influence, so avoid driving and operating machinery during this treatment.
Side Effects of Tecentriq 840mg Injection
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Serious
- Inflammation (lung, liver, intestine, thyroid, adrenal glands, and pituitary gland)
- Type 1 diabetes
- Inflammation of the brain, heart muscle, kidney, muscle
- Severe skin reaction
- Inflammation of problem with nerve
Common
- Fever
- Loss of appetite
- Urinary tract infection
- Pain in the joints, muscles, and bones
- Headache
- Hair loss
- Numbness in hands and feet
- Sensitivity to sun
- Constipation
- Low oxygen level
- High blood sugar
- Pain in stomach, mouth, and throat
Word of Advice
Notify our doctor if you are taking or have recently taken any other medications. Before starting the treatment, it is advised to have a blood test and general health check-up. Report to your doctor if you experience any side effects; your doctor may delay. This medicine is not recommended for children and adolescents under 18 years. Before starting the treatment, inform your doctor if your cancer cell has spread to the brain.
FAQs
Q 1. Is Tecentriq 840mg chemotherapy medicine?
No, It is not a type of chemotherapy. Tecentriq 840mg is a monoclonal antibody, a type of immunotherapy medication that works by stimulating the body's immune system to attack cancer cells.
Q 2. What is the Tecentriq 840mg brand name?
Tecentriq 840mg is marketed under the brand name "Tecentriq."
Q 3. Can Tecentriq 840mg be used in combination with other cancer treatments?
Yes, Tecentriq 840mg is often used with other anticancer medicine to treat certain types of cancer.
Q 4. How long can you stay on immunotherapy?
Many people stay on immunotherapy for about two years. The duration of immunotherapy depends on the stage of cancer and how well one responds to the treatment.
Q 5. What type of cancers does Tecentriq 840mg treat?
Tecentriq 840mg is prescribed to treat urothelial carcinoma, liver cancer (hepatocellular carcinoma), small cell and non-small cell lung cancer, triple-negative breast cancer, and melanoma.
Fact Box of Tecentriq 840mg Injection
Molecule name: Atezolizumab | Therapeutic class: Antineoplastics |
Pharmacological class: Monoclonal antibody | Indications: 1. Urothelial carcinoma 2. Non-small cell lung cancer 3. small cell lung cancer 4. Triple-negative breast cancer 5. Hepatocellular carcinoma |
References
- Roche, Electronic Medicines Compendium (EMC) [Revised on Feb 2022], [Accessed on 25th April 2023], Tecentriq 1,200 mg concentrate for solution for infusion - Patient Information Leaflet (PIL) - (emc) (medicines.org.uk)
- Genentech Inc, US Food and Drug Administration [Revised on Oct 2021] [Accessed on 25th April 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761034s028lbl.pdf
- Anton Wellstein, Giuseppe Giaccone, Michael B. Atkins, and Edward A. Sausville, Pathway-Targeted Therapies: Monoclonal Antibodies, Protein Kinase Inhibitors, and Various Small Molecules, Goodman & Gilman's Pharmacological
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
